title: Letter to the editor: economic evaluation of dabigatran etexilate.
authors.forename: Rachel
authors.initials: R
authors.lastname: Caggy
authors.forename: Thomas
authors.initials: T
authors.lastname: O'Rorke
authors.forename: Priyam
authors.initials: P
authors.lastname: Patel
authors.forename: Khalid M
authors.initials: KM
authors.lastname: Kamal
mesh_terms: D001562:Benzimidazoles / Q000191:economics*; D005260:Female; D005343:Fibrinolytic Agents / Q000191:economics*; D006801:Humans; D008297:Male; D009985:Orthopedics; D011183:Postoperative Complications / Q000517:prevention & control*; D011322:Primary Prevention; D011725:Pyridines / Q000191:economics*; D054556:Venous Thromboembolism / Q000517:prevention & control*
chemical_list: D001562:Benzimidazoles; D005343:Fibrinolytic Agents; D011725:Pyridines